期刊文献+

老年冠心病患者血清脑钠肽的变化及临床意义

暂未订购
导出
摘要 目的:观察不同类型冠心病患者血清脑钠肽(NT-proBNP)的变化,研究其与肌钙蛋白T(TNT)和肌酸激酶同工酶(CK-MB)的相关性,探讨其临床意义。方法:检测260例冠心病患者(包括稳定型心绞痛147例、不稳定型心绞痛78例、急性心肌梗死35例)的NTproBNP、TNT、CK-MB的水平,30例健康者作为对照组,比较不同组别NT-proBNP的差异及其与TNT、CK-MB的关系。结果:对照组、稳定型心绞痛组(SAP)、不稳定型心绞痛组(UAP)、急性心肌梗死组(AMI)的血清NT-proBNP浓度分别为(76.5±16.9)ng/L、(82.6±20.8)ng/L、(2168±366.7)ng/L、(6780±1025.6)ng/L,AMI组与其他组差异具有统计学意义(P<0.001)。AMI组NT-proBNP与TNT(P<0.001)、CK-MB(P<0.01)浓度变化呈正相关。结论:不同临床类型的NT-proBNP浓度存在差异,可作为冠心病临床分型指标,对疾病的预后观察具有重要意义,与心肌坏死程度相关。 Objective :To investigate the changes of serum NT-proBNP levels and explore the correlations with TNT and CK-MB in different types of patients with coronary atherosclerotic heart disease, also to probe the clinical values. Methods:Examine serum NT-proBNP, TNT, CK-MB in 260 patients (147 with stable angina pectoris, 78with unstable angina pectoris, 35 with acute myocardial infarction), together with 30 healthy controls to compare the difference of NT-proBNP level and its relationships with TNT and CK-MB in each group. Results: The serum concentrations of healthy control, SAP, UAP and AMI group are respectively (76.5±16.9)ng/L, (82.6±20.8)ng/L, (2168±366.7) rig/L, (6780±1025.6)ng/L. The difference is statistically significant between AMI and other three groups, which NT-proBNP is positively re- lated with density changes of TNT(P〈0.001 )and CK-MB(P〈0.01 ). Conclusion: Sufferers of different clinical types have different NT-proBNP density and the level is relevant to the degree of myocardial necrosis. NT-proBNP may be a clinical classification index and has important significance in prognosis observations.
出处 《内蒙古中医药》 2013年第35期9-10,共2页 Inner Mongolia Journal of Traditional Chinese Medicine
关键词 冠心病 血清脑钠肽 肌钙蛋白T coronary atherosclerotic heart disease: serum NT-oroBNP:trooonin T
  • 相关文献

参考文献5

二级参考文献20

  • 1高伟,王士雯,赵玉生.脑钠肽前体N末端片段在心血管病研究应用中的现状[J].中华心血管病杂志,2004,32(8):759-761. 被引量:65
  • 2徐焰,彭道荣,陈灿磊,张小宁,余妍,孙怡群,郝晓柯.血浆脑钠肽水平对冠心病诊断价值的初步探讨[J].现代检验医学杂志,2006,21(3):58-60. 被引量:5
  • 3Yoshihiko,Askio O,Terayo Y,et al. Application of NT-proBNP and BNP measurements in cardiac care: a more discreming marker for the detection and evaluation of heart failure [J].The European Journal of Heart Failure, 2.004, (6) :295.
  • 4Meune C, Martins E, Fulla Y, et al. New biological markers for acute coro- nary artery diseose [J] .J Malvese,2003,28(5) :251.
  • 5Oltrona L,Ardissino D, Merlini PA,et al. C-reactive protein devation and early outcome in patieats Mth unstable p~oris [J] .Am J Cardiol, 1997, 80(8) : 1002.
  • 6Jeffery L,Anderson MD,Facc JF,et al.Evalualion of C Creative protein, an inflammatory marker and infection serology as risk factors for coronary, disease and myocardial infarction [J].J Am Coil Cardiol, 1998,32(1): 35.
  • 7Mueller T, Gegenhuber A, PoeLz W, et al. Biochemical diagnosis of impaired left. Ventrilar ejection fraction-comparison of the diagaostic accuracy of brain natriuretic peptide(BNP)and am ino terminal proBNP(NT- proBNP) [J]. Clin Chem Lab Med, 2004,42(2) : 159.
  • 8CRP Selhub J, D Angelo A. Relationship between homocysteine and thrombotic disease [J].Am J Med Sd,1998,316(2):129.
  • 9Talwar S,Downie PF,Squire IB,et al.Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis[].European Journal of Heart Failure.2001
  • 10Jernberg T,Stridsberg M,Venge P,et al.N-terminal pro-brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation[].Journal of the American College of Cardiology.2002

共引文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部